Two Roche Diagnostics Corp. executives recently spoke enthusiastically about the company's progress toward personalized health care. Central to unlocking this potential is the combination of using data from multiple sources, the use of machine learning to further knowledge and understanding and partnering with others, including non-traditional players, to combine their expertise with Roche's.
"We're at a pivotal moment [in health care] and we're seeing a real convergence of medical knowledge, technology and data...